Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?
Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?